Korro Bio (KRRO) Research & Development (2018 - 2026)

Korro Bio (KRRO) has reported Research & Development for 9 consecutive years, with $13.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development fell 32.52% year-over-year to $13.6 million; the trailing twelve-month figure through Jun 2026 stood at $51.3 million (down 29.47% YoY), and the FY2025 full-year result was $65.6 million, up 3.05% from the prior year.
• Research & Development rose to $13.6 million in Q2 2026 per KRRO's latest filing, from $13.0 million in the prior quarter.
• Across five years, Research & Development topped out at $20.1 million in Q2 2025 and bottomed at $3.4 million in Q4 2022.
• Historically, Research & Development has averaged $14.1 million across 5 years, with a median of $13.8 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Research & Development sank 73.09% in 2022, then surged 349.36% in 2023.
• Over 5 years, Research & Development stood at $3.4 million in 2022, then soared by 349.36% to $15.4 million in 2023, then advanced by 9.99% to $17.0 million in 2024, then plunged by 35.24% to $11.0 million in 2025, then increased by 23.7% to $13.6 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $13.6 million, $13.0 million, and $11.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.